Artelo Biosciences shares jump after a glaucoma study deal to test ART27.13, a new treatment targeting eye pressure in patients.
Nano-Cap Artelo Biosciences Stock Explodes — Glaucoma Study Collaboration Ignites Rally
Importance Rank:
1